Challenges, Current Status and Future Perspectives of Proteomics in Improving Understanding, Diagnosis and Treatment of Vascular Disease

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 3, 2009, Pages 346-355

  Moxon, J V ^a   Padula, M P ^b   Herbert, B R ^b   Golledge, J ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Mass spectrometry; Proteomics; Secretome; Vascular medicine

Indexed keywords

GENETIC POLYMORPHISM; GENOMICS; GLYCOBIOLOGY; HUMAN; MASS SPECTROMETRY; METABOLOMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEOMICS; REVIEW; TRANSCRIPTOMICS; VASCULAR DISEASE;

BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MASS SPECTROMETRY; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; VASCULAR DISEASES;

EID: 68249096526     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.05.008     Document Type: Review

References (65)

1. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250 10 (1975) 4007-4021
2. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19 3 (1999) 1720-1730
3. Gomase V.S., and Tagore S. Transcriptomics. Curr Drug Metab 9 3 (2008) 245-249
4. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., et al. The sequence of the human Genome. Science 291 5507 (2001) 1304-1351
5. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., et al. Initial sequencing and analysis of the human genome. Nature 409 6822 (2001) 860-921
6. Humphery-Smith I. A human proteome project with a beginning and an end. Proteomics 4 (2006) 2519-2521
7. Craenburg E.C., Brandenburg V.M., Vermeer C., Stenger M., Muhlenbruch G., et al. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 101 2 (2009) 359-366
8. de Roos B., Geelen A., Ross K., Rucklidge G., Reid M., et al. Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics 8 10 (2008) 1965-1974
9. Lepedda A.J., Cigliano A., Cherchi G.M., Spirito R., Maggioni M., et al. A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 2008 (2008)
10. Yin W., Czuchlewski M.D., and Peerschke E.I. Development of proteomic signatures of platelet activation using surface-enhanced laser desorption/ionization technology in a clinical setting. Am J Clin Pathol 129 (2008) 862-869
11. Liu X., Shen J., Zhan R., Wang X., Wang X., et al. Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells. Biochim Biophys Acta (2008)
12. Qiu J., Gao H.Q., Liang Y., Yu H., and Zhou R.H. Comparative proteomics analysis reveals role of heat shock protein 60 in digoxin-induced toxicity in human endothelial cells. Biochim Biophys Acta 1784 11 (2008) 1857-1864
13. Eman M.R., Regan-Klapisz E., Pinkse M.W., Koop I.M., Haverkamp J., et al. Protein expression dynamics during replicative senescence of endothelial cells studied by 2-D difference in-gel electrophoresis. Electrophoresis 27 8 (2006) 1669-1682
14. Urbonavicius S., Lindholt J.S., Vorum H., Urbonaviciene G., Henneberg E.W., et al. Proteomic identification of differentially expressed proteins in aortic wall of patients with ruptured and nonruptured abdominal aortic aneurysms. J Vasc Surg 2008 (2008)
15. Wilkins M.R., Gasteiger E., Sanchez J.C., Bairoch A., and Hochstrasser D.F. Two-dimensional gel electrophoresis for proteome projects: the effects of protein hydrophobicity and copy number. Electrophoresis 19 8-9 (1998) 1501-1505
16. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 97 17 (2000) 9390-9395
17. Barrett J., Brophy P.M., and Hamilton J.V. Analysing proteomic data. Int J Parasitol 35 5 (2005) 543-553
18. Molloy M.P., Phadke N.D., Chen H., Tyldesley R., Garfin D.E., et al. Profiling the alkaline membrane proteome of Caulobacter crescentus with two-dimensional electrophoresis and mass spectrometry. Proteomics 2 7 (2002) 899-910
19. Patton W.F., Schulenberg B., and Steinberg T.H. Two-dimensional gel electrophoresis; better than a poke in the ICAT?. Curr Opin Biotechnol 13 4 (2002) 321-328
20. Mayr M., Chung Y.L., Mayr U., Yin X., Ly L., et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol 25 10 (2005) 2135-2142
21. Unlu M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single method for detecting changes in protein extracts. Electrophoresis 18 11 (1997) 2071-2077
22. Sidibe A., Yin X., Tarelli E., Xiao Q., Zampetaki A., et al. Integrated membrane protein analysis of mature and embryonic stem cell-derived smooth muscle cells using a novel combination of CyDye/biotin labeling. Mol Cell Proteomics 6 10 (2007) 1788-1797
23. Aebersold R., and Mann M. Mass spectrometry-based proteomics. Nature 422 6928 (2003) 198-207
24. Iliuk A., Galan J., and Tao W.A. Playing tag with quantitative proteomics. Anal Bioanal Chem (2008)
25. Haqqani A.S., Nesic M., Preston E., Baumann E., Kelly J., et al. Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT-nanoLC-MS/MS. FASEB J 19 13 (2005) 1809-1821
26. Haqqani A.S., Kelly J., Baumann E., Haseloff R.F., Blasig I.E., et al. Protein markers of ischemic insult in brain endothelial cells identified using 2D gel electrophoresis and ICAT-based quantitative proteomics. J Proteome Res 6 1 (2007) 226-239
27. Sethuraman M., McComb M.E., Huang H., Heibeck T., Costello C.E., et al. Isotope-coded affinity tag (ICAT) approach to redox proteomics: identification and quantitation of oxidant-sensitive cysteine thiols in complex protein mixtures. J Proteome Res 3 6 (2004) 1228-1233
28. Sui J., Tan T.L., Zhang J., Ching C.B., and Chen W.N. iTRAQ-coupled 2D LC-MS/MS analysis on protein profile in vascular smooth muscle cells incubated with S- and R-enantiomers of propranolol: possible role of metabolic enzymes involved in cellular anabolism and antioxidant activity. J Proteome Res 6 5 (2007) 1643-1651
29. Sui J., Zhang J., Tabn T.L., Ching C.B., and Chen W.N. Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol Cell Proteomics 7 6 (2008) 1007-1018
30. Guo Y., Singleton P.A., Rowshan A., Gucek M., Cole R.N., et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol. Cell. Proteomics 6 4 (2007) 689-696
31. Wu C.C., MacCoss M.J., Howell K.E., Matthews D.E., and Yates III J.R. Metabolic labeling of mammalian organisms with stable isotopes for quantitative proteomic analysis. Anal Chem 76 (2004) 4951-4959
32. McClatchy D.B., Dong M.Q., Wu C., Venable J.D., and Yates III J.R. 15N metabolic labelling of mammalian tissue with slow protein turnover. J Proteome Res 6 5 (2007) 2005-2010
33. Ong S.E., and Mann M. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat Protoc 1 6 (2006) 2650-2660
34. Kruger M., Moser M., Ussar S., Thievessen I., Lubar C.A., et al. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 134 2 (2008) 353-364
35. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1 11 (2002) 845-867
36. Mayr M., Madhu B., and Xu Q. Proteomics and metabolomics combined in cardiovascular research. Trends Cardiovasc Med 17 2 (2007) 43-48
37. McFarlane I., Bomford A., and Sherwood R. Liver disease and laboratory medicine (2000), ACB Venture Publications, London
38. Sacher R.A., and McPherson R.A. Widmann's clinical interpretation of laboratory tests (2000), F.A. Davis Co,, Philadelphia
39. Alvarez-Llamas G., de la Cuesta F., Barderas M.G., Darde V., Padial L.R., et al. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Rev Proteomics 5 5 (2008) 679-691
40. Pula G., Perera S., Prokopi M., Sidibe A., Boulanger C.M., et al. Proteomic analysis of secretory proteins and vesicles in vascular research. Proteomics Clin Appl 2 (2008) 882-891
41. Lu Q., Murugesan N., Macdonald J.A., Wu S.L., Pachter J.S., et al. Analysis of mouse brain microvascular endothelium using immuno-laser capture microdissection coupled to a hybrid linear ion trap with Fourier transform-mass spectrometry proteomics platform. Electrophoresis 29 12 (2008) 2689-2695
42. Wu J., Liu W., Sousa E., Qiu Y., Pittman D.D., et al. Proteomic identification of endothelial proteins isolated in situ from atherosclerotic aorta via systemic perfusion. J Proteome Res 6 12 (2007) 4728-4736
43. Duran M.C., Martin-Ventura J.L., Mas S., Barderas M.G., Darde V.M., et al. Characterization of the human atheroma plaque secretome by proteomic analysis. Methods Mol Biol 357 (2007) 141-150
44. Duran M.C., Mas S., Martin-Ventura J.L., Meilhac O., Michel J.B., et al. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 3 6 (2003) 973-978
45. Pellitteri-Hahn M.C., Warren M.C., Didier D.N., Winkler E.L., Mirza S.P., et al. Improved mass spectrometric proteomic profiling of the secretome of rat vascular endothelial cells. J Proteome Res 5 10 (2006) 2861-2864
46. Peterson D.B., Sander T., Kaul S., Wakim B.T., Halligan B., et al. Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles. Proteomics 8 12 (2008) 2430-2446
47. Dupont A., Corseaux D., Dekeyzer O., Drobecq H., Guihot A.L., et al. The proteome and secretome of human arterial smooth muscle cells. Proteomics 5 2 (2005) 585-596
48. Gao B.B., Stuart L., and Feener E.P. Label-free quantitative analysis of 1D-PAGE LC/MS/MS proteome: application on angiotensin II stimulated smooth muscle cells secretome. Mol. Cell. Proteomics 7 12 (2008) 2399-2409
49. Zwickl H., Traxler E., Staettmer S., Parzefall W., Grasl-Kraupp B., et al. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 26 14 (2005) 2779-2785
50. Gronborg M., Kristiansen T.Z., Iwahori A., Chang R., Reddy R., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5 1 (2006) 157-171
51. An E., Lu X., Flippin J., Devaney J.M., Halligan B., et al. Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. J Proteome Res 5 10 (2006) 2599-2610
52. Alvarez-Llamas G., Szalowska E., de Vries M.P., Weening D., Landman K., et al. Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 6 4 (2007) 589-600
53. Martens L., Hermjakob H., Jones P., Adamski M., Taylor C., et al. PRIDE: the proteomics identifications database. Proteomics 5 (2005) 3537-3545
54. Jones P., Cote R.G., Martens L., Quinn A.F., Taylor C.F., et al. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res. 34 Database issue (2006) D659-D663
55. Taylor C.F., Hermjakob Jr. H., Julian R.K., Garavelli J.S., Aebersold R., et al. The work of the human proteome organisation's proteomics standards initiative (HUPO PSI). OMICS 10 2 (2006) 145-151
56. Hogan J.M., Higdon R., and Kolker E. Experimental standards for high-throughput proteomics. OMICS 10 2 (2006) 152-157
57. Lenth R.V. Some practical guidelines for effective sample size determination. Amer Statistician 55 3 (2001) 187-193
58. Biron D.G., Brun C., Lefevre T., Lebarbenchon C., Loxdale H.D., et al. The pitfalls of proteomics experiments without the correct use of bioinformatics tools. Proteomics 6 (2006) 5577-5596
59. Dreisbach A., Otto A., Becher D., Hammer E., Teumer A., et al. Monitoring of changes in the membrane proteome during stationary phase adaptation of Bacillus subtilis using in vivo labeling techniques. Proteomics 8 10 (2008) 2062-2076
60. Graumann J., Hubner N.C., Kim J.B., Ko K., Moser M., et al. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics 7 4 (2008) 672-683
61. Callesen A.K., Vach W., Jorgensen P.E., Cold S., Mogensen O., et al. Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review. J Proteome Res 7 4 (2008) 1395-1402
62. von Zur Muhlen C., Schiffer E., Zuerbig P., Kellmann M., Brasse M., et al. Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteome Res 8 1 (2009) 335-345
63. Krycer J.R., Pang C.N., and Wilkins M.R. High throughput protein-protein interaction data: clues for the architecture of protein complexes. Proteome Sci 26 6 (2008) 32
64. Huang K.Y., Filarsky M., Padula M.P., Raftery M.J., Herbert B.R., et al. Micropreparative fractionation of the complexome by blue native continuous elution electrophoresis. Proteomics 9 9 (2009) 2494-2502
65. Perlman D.H., Bauer S.M., Houman A., Bryan N.S., Garcia-Saura M.F., et al. Mechanistic insights into nitrite-induced cardioprotection using and integrated metabonomic/proteomic approach. Circ Res 104 6 (2009) 796-804